Analysts have been eager to weigh in on the Healthcare sector with new ratings on Emergent Biosolutions (EBS – Research Report), Incyte (INCY – Research Report) and Harmony Biosciences Holdings (HRMY – Research Report).
Emergent Biosolutions (EBS)
Chardan Capital analyst Keay Nakae reiterated a Buy rating on Emergent Biosolutions today and set a price target of $65.00. The company’s shares closed last Monday at $34.23.
According to TipRanks.com, Nakae is a 4-star analyst with an average return of
Currently, the analyst consensus on Emergent Biosolutions is a Moderate Buy with an average price target of $49.67.
Mizuho Securities analyst Mara Goldstein maintained a Hold rating on Incyte today and set a price target of $95.00. The company’s shares closed last Monday at $77.40.
According to TipRanks.com, Goldstein is a 2-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Incyte with a $84.70 average price target, which is a 9.4% upside from current levels. In a report issued on July 28, Wells Fargo also initiated coverage with a Hold rating on the stock with a $76.00 price target.
Harmony Biosciences Holdings (HRMY)
Needham analyst Ami Fadia maintained a Buy rating on Harmony Biosciences Holdings today and set a price target of $60.00. The company’s shares closed last Monday at $49.23.
According to TipRanks.com, Fadia is a 1-star analyst with an average return of
Harmony Biosciences Holdings has an analyst consensus of Strong Buy, with a price target consensus of $60.25, a 18.8% upside from current levels. In a report issued on July 27, Mizuho Securities also maintained a Buy rating on the stock with a $64.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on EBS:
- Here’s Why Lexicon Stock Rallied 7.6% in Monday’s Extended Trade
- MKM Partners Believes Molson Coors (TAP) Still Has Room to Grow
- Colliers acquires leading Australian engineering services firm
- Man Group PLC : Form 8.3 – CareTech Holdings plc
- Esperion Reports Second Quarter 2022 Financial Results and Provides Company Update